He Jie, Xue Kaming, Fan Fei, Li Lin, Rao Xinyu, Liu Wei, Nie Chuansheng
Department of Neurosurgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.
Department of Traditional Chinese Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.
J Cell Mol Med. 2024 Apr;28(8):e18332. doi: 10.1111/jcmm.18332.
The role of KIAA0040 role in glioma development is not yet understood despite its connection to nervous system diseases. In this study, KIAA0040 expression levels were evaluated using qRT-PCR, WB and IHC, and functional assays were conducted to assess its impact on glioma progression, along with animal experiments. Moreover, WB was used to examine the impact of KIAA0040 on the JAK2/STAT3 signalling pathway. Our study found that KIAA0040 was increased in glioma and linked to tumour grade and poor clinical outcomes, serving as an independent prognostic factor. Functional assays showed that KIAA0040 enhances glioma growth, migration and invasion by activating the JAK2/STAT3 pathway. Of course, KIAA0040 enhances glioma growth by preventing tumour cell death and promoting cell cycle advancement. Our findings suggest that targeting KIAA0040 could be an effective treatment for glioma due to its role in promoting aggressive tumour behaviour and poor prognosis.
尽管KIAA0040与神经系统疾病有关,但其在胶质瘤发展中的作用尚不清楚。在本研究中,使用qRT-PCR、WB和IHC评估了KIAA0040的表达水平,并进行了功能试验以评估其对胶质瘤进展的影响,同时进行了动物实验。此外,使用WB检测KIAA0040对JAK2/STAT3信号通路的影响。我们的研究发现,KIAA0040在胶质瘤中表达增加,与肿瘤分级和不良临床结果相关,是一个独立的预后因素。功能试验表明,KIAA0040通过激活JAK2/STAT3通路增强胶质瘤的生长、迁移和侵袭。当然,KIAA0040通过防止肿瘤细胞死亡和促进细胞周期进程来增强胶质瘤的生长。我们的研究结果表明,由于KIAA0040在促进肿瘤侵袭行为和不良预后方面的作用,靶向KIAA0040可能是治疗胶质瘤的有效方法。
J Cell Mol Med. 2024-4
J Int Med Res. 2024-12
J Transl Med. 2025-4-10
Cell Death Dis. 2023-10-9
J Cell Mol Med. 2023-1
Biomedicines. 2020-12-21